Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-409 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0057 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0071 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6851 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6855 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-062 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6849 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-17 |
filingDate |
2019-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2021-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-WO2019172110-A1 |
titleOfInvention |
Conjugation of blood vessel-targeting antibody with photosensitizer |
abstract |
Provide a conjugate that can be used for photoimmunotherapy. A photosensitizer (12) whose absorption wavelength range overlaps the wavelength range from red light to near-infrared light against the antibody (11) specific for vascular endothelial cell growth factor receptor (VEGFR) (17). Joining conjugate (10). A photosensitizer (12) is applied by binding a conjugate (10) to a new blood vessel located in the affected area by an antigen-antibody reaction and irradiating the affected area with excitation light (20) having a wavelength of 660 to 740 nm. It excites and damages new blood vessels by photosensitizing action (21). |
priorityDate |
2018-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |